These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26043941)

  • 41. Bioelectrical Impedance Phase Angle as an Indicator of Malnutrition in Hospitalized Children with Diagnosed Inflammatory Bowel Diseases-A Case Control Study.
    Więch P; Dąbrowski M; Bazaliński D; Sałacińska I; Korczowski B; Binkowska-Bury M
    Nutrients; 2018 Apr; 10(4):. PubMed ID: 29673210
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The comorbid occurrence of other diagnoses in patients with ulcerative colitis and Crohn's disease.
    Cucino C; Sonnenberg A
    Am J Gastroenterol; 2001 Jul; 96(7):2107-12. PubMed ID: 11467640
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F; Portela F
    BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Histopathological characterization of cholecystectomy specimens in patients with inflammatory bowel disease.
    Lin J; Shen B; Lee HJ; Goldblum JR
    J Crohns Colitis; 2012 Oct; 6(9):895-9. PubMed ID: 22397872
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Getting personal: a review of sexual functioning, body image, and their impact on quality of life in patients with inflammatory bowel disease.
    Jedel S; Hood MM; Keshavarzian A
    Inflamm Bowel Dis; 2015 Apr; 21(4):923-38. PubMed ID: 25789923
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The value of focally enhanced gastritis in the diagnosis of pediatric inflammatory bowel diseases.
    Roka K; Roma E; Stefanaki K; Panayotou I; Kopsidas G; Chouliaras G
    J Crohns Colitis; 2013 Nov; 7(10):797-802. PubMed ID: 23207168
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A national survey on the patterns of treatment of inflammatory bowel disease in Canada.
    Hilsden RJ; Verhoef MJ; Best A; Pocobelli G
    BMC Gastroenterol; 2003 Jun; 3():10. PubMed ID: 12791168
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Overweight and obesity in children with newly diagnosed inflammatory bowel disease.
    Pituch-Zdanowska A; Banaszkiewicz A; Dziekiewicz M; Łazowska-Przeorek I; Gawrońska A; Kowalska-Duplaga K; Iwańczak B; Klincewicz B; Grzybowska-Chlebowczyk U; Walkowiak J; Albrecht P
    Adv Med Sci; 2016 Mar; 61(1):28-31. PubMed ID: 26355738
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].
    Von Tirpitz C; Pischulti G; Klaus J; Rieber A; Brückel J; Böhm BO; Adler G; Reinshagen M
    Z Gastroenterol; 1999 Jan; 37(1):5-12. PubMed ID: 10091278
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inflammatory bowel disease and predisposition to osteopenia.
    Cowan FJ; Warner JT; Dunstan FD; Evans WD; Gregory JW; Jenkins HR
    Arch Dis Child; 1997 Apr; 76(4):325-9. PubMed ID: 9166024
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus.
    Bourreille A; Ignjatovic A; Aabakken L; Loftus EV; Eliakim R; Pennazio M; Bouhnik Y; Seidman E; Keuchel M; Albert JG; Ardizzone S; Bar-Meir S; Bisschops R; Despott EJ; Fortun PF; Heuschkel R; Kammermeier J; Leighton JA; Mantzaris GJ; Moussata D; Lo S; Paulsen V; Panés J; Radford-Smith G; Reinisch W; Rondonotti E; Sanders DS; Swoger JM; Yamamoto H; Travis S; Colombel JF; Van Gossum A;
    Endoscopy; 2009 Jul; 41(7):618-37. PubMed ID: 19588292
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vitamins A and E serum levels in children and young adults with inflammatory bowel disease: effect of disease activity.
    Bousvaros A; Zurakowski D; Duggan C; Law T; Rifai N; Goldberg NE; Leichtner AM
    J Pediatr Gastroenterol Nutr; 1998 Feb; 26(2):129-35. PubMed ID: 9481625
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Bone mineral density in inflammatory bowel diseases in children].
    Szumera M; Landowski P; Kamińska B; Góra-Gebka M; Popadiuk S; Renke J
    Med Wieku Rozwoj; 2006; 10(2):445-51. PubMed ID: 16825715
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Altered levels of biochemical indices of bone turnover and bone-related vitamins in patients with Crohn's disease and ulcerative colitis.
    Gilman J; Shanahan F; Cashman KD
    Aliment Pharmacol Ther; 2006 Apr; 23(7):1007-16. PubMed ID: 16573803
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A meta-analysis on sleep quality in inflammatory bowel disease.
    Ballesio A; Zagaria A; Baccini F; Micheli F; Di Nardo G; Lombardo C
    Sleep Med Rev; 2021 Dec; 60():101518. PubMed ID: 34214847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Special situations in inflammatory bowel disease: First Latin American consensus of the Pan American Crohn's and Colitis Organisation (PANCCO) (Second part).
    Yamamoto-Furusho JK; Bosques-Padilla F; Daffra P; De Paula JA; Etchevers J; Galiano MT; Ibañez P; Juliao F; Kotze PG; Marroquín de la Garza JM; Monreal Robles R; Rocha JL; Steinwurz F; Vázquez-Frías R; Veitia G; Zaltman C
    Rev Gastroenterol Mex; 2017; 82(2):134-155. PubMed ID: 28318706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.